Literature DB >> 7350297

Somatostatin treatment of insulin excess due to beta-cell adenoma in a neonate.

H F Kitson, R B McCrossin, M Jimenez, A Middleton, M Silink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350297     DOI: 10.1016/s0022-3476(80)80353-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

Authors:  J M Hawdon; M P Ward Platt; W H Lamb; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Plasma somatostatin concentration in the preterm neonate.

Authors:  L Sann; J A Chayvialle; F Descos
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

3.  Gastroenteropancreatic endocrine tumors.

Authors:  C Weil
Journal:  Klin Wochenschr       Date:  1985-05-15

4.  Pancreatic venous samplings in infants and children with primary hyperinsulinism.

Authors:  F Brunelle; V Negre; M O Barth; C N Fekete; P Czernichow; J M Saudubray; F Kuntz; T Tach; D Lallemand
Journal:  Pediatr Radiol       Date:  1989

Review 5.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

6.  Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin.

Authors:  K Tiedemann; J Pritchard; R Long; S R Bloom
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

7.  Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis.

Authors:  L W Martin; F C Ryckman; C A Sheldon
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

8.  Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995.

Authors:  R Oosterom; T Verleun; P Uitterlinden; H A Bruining; G J Bruining; L Verschoor; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.